Cargando…
Intravitreal bevacizumab injections for diabetic macular edema – predictors of response: a retrospective study
BACKGROUND: Outcomes of intravitreal antivascular endothelial growth factor injections are variable among patients with diabetic macular edema (DME). The aim of this study was to determine the ocular and systemic predictors of DME response to intravitreal bevacizumab (IVB). METHODS: Retrospective re...
Autores principales: | Joshi, Lavnish, Bar, Asaf, Tomkins-Netzer, Oren, Yaganti, Satish, Morarji, Jiten, Vouzounis, Panayiotis, Seguin-Greenstein, Sophie, Taylor, Simon R, Lightman, Sue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085296/ https://www.ncbi.nlm.nih.gov/pubmed/27799737 http://dx.doi.org/10.2147/OPTH.S109809 |
Ejemplares similares
-
Rhizobium radiobacter Endophthalmitis following Intravitreal Ranibizumab Injection
por: Joshi, Lavnish, et al.
Publicado: (2012) -
Combined Infliximab and Rituximab in Necrotising Scleritis
por: Morarji, Jiten, et al.
Publicado: (2012) -
A Meta-Analysis of Studies Evaluating Visual and Anatomical Outcomes in Patients with Treatment Resistant Neovascular Age-Related Macular Degeneration following Switching to Treatment with Aflibercept
por: Seguin-Greenstein, Sophie, et al.
Publicado: (2016) -
Valacyclovir in the treatment of acute retinal necrosis
por: Taylor, Simon RJ, et al.
Publicado: (2012) -
Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema
por: Seo, Jeong Won, et al.
Publicado: (2009)